180 related articles for article (PubMed ID: 24613069)
1. Selective inhibition of histone deacetylase 6 alters the composition of circulating blood cells in a lethal septic model.
Zhao T; Li Y; Liu B; Halaweish I; Mazitschek R; Alam HB
J Surg Res; 2014 Aug; 190(2):647-54. PubMed ID: 24613069
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model.
Zhao T; Li Y; Liu B; Pan B; Cheng X; Georgoff P; Alam HB
J Trauma Acute Care Surg; 2016 Jan; 80(1):34-40; discussion 40-1. PubMed ID: 26491797
[TBL] [Abstract][Full Text] [Related]
3. Selective histone deacetylase-6 inhibition attenuates stress responses and prevents immune organ atrophy in a lethal septic model.
Zhao T; Li Y; Bronson RT; Liu B; Velmahos GC; Alam HB
Surgery; 2014 Aug; 156(2):235-42. PubMed ID: 24947640
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.
Li Y; Zhao T; Liu B; Halaweish I; Mazitschek R; Duan X; Alam HB
J Trauma Acute Care Surg; 2015 Feb; 78(2):378-85. PubMed ID: 25757125
[TBL] [Abstract][Full Text] [Related]
5. Protective Effect of Tubastatin A in CLP-Induced Lethal Sepsis.
Deng Q; Zhao T; Pan B; Dennahy IS; Duan X; Williams AM; Liu B; Lin N; Bhatti UF; Chen E; Alam HB; Li Y
Inflammation; 2018 Dec; 41(6):2101-2109. PubMed ID: 30047002
[TBL] [Abstract][Full Text] [Related]
6. Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model.
Cheng X; Liu Z; Liu B; Zhao T; Li Y; Alam HB
J Surg Res; 2015 Jul; 197(1):39-44. PubMed ID: 25837686
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis.
Zhao T; Li Y; Liu B; Wu E; Sillesen M; Velmahos GC; Halaweish I; Alam HB
Surgery; 2014 Aug; 156(2):214-20. PubMed ID: 24957668
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase III as a potential therapeutic target for the treatment of lethal sepsis.
Zhao T; Li Y; Liu B; Bronson RT; Halaweish I; Alam HB
J Trauma Acute Care Surg; 2014 Dec; 77(6):913-9; discussion 919. PubMed ID: 25051385
[TBL] [Abstract][Full Text] [Related]
9. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
[TBL] [Abstract][Full Text] [Related]
10. Citrullinated histone H3: a novel target for the treatment of sepsis.
Li Y; Liu Z; Liu B; Zhao T; Chong W; Wang Y; Alam HB
Surgery; 2014 Aug; 156(2):229-34. PubMed ID: 24957671
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis.
Takebe M; Oishi H; Taguchi K; Aoki Y; Takashina M; Tomita K; Yokoo H; Takano Y; Yamazaki M; Hattori Y
J Surg Res; 2014 Apr; 187(2):559-70. PubMed ID: 24290430
[TBL] [Abstract][Full Text] [Related]
12. A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model.
Lee J; Hong EC; Jeong H; Hwang JW; Kim H; Bae EK; Ahn JK; Choi YL; Han J; Cha HS; Koh EM
Int J Rheum Dis; 2015 Jun; 18(5):514-23. PubMed ID: 25530272
[TBL] [Abstract][Full Text] [Related]
13. Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice.
Zhang L; Liu C; Wu J; Tao JJ; Sui XL; Yao ZG; Xu YF; Huang L; Zhu H; Sheng SL; Qin C
J Alzheimers Dis; 2014; 41(4):1193-205. PubMed ID: 24844691
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of histone deacetylase 6 restores intestinal tight junction in hemorrhagic shock.
Chang Z; Li Y; He W; Liu B; Duan X; Halaweish I; Bambakidis T; Pan B; Liang Y; Nikolian VC; Georgoff P; Alam HB
J Trauma Acute Care Surg; 2016 Sep; 81(3):512-9. PubMed ID: 27257709
[TBL] [Abstract][Full Text] [Related]
15. Novel pharmacologic treatment attenuates septic shock and improves long-term survival.
Zhao T; Li Y; Liu B; Liu Z; Chong W; Duan X; Deperalta DK; Velmahos GC; Alam HB
Surgery; 2013 Aug; 154(2):206-13. PubMed ID: 23889949
[TBL] [Abstract][Full Text] [Related]
16. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.
Ahmad A; Vieira JC; de Mello AH; de Lima TM; Ariga SK; Barbeiro DF; Barbeiro HV; Szczesny B; Törö G; Druzhyna N; Randi EB; Marcatti M; Toliver-Kinsky T; Kiss A; Liaudet L; Salomao R; Soriano FG; Szabo C
Pharmacol Res; 2019 Jul; 145():104263. PubMed ID: 31071432
[TBL] [Abstract][Full Text] [Related]
17. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HDAC6 by Tubastatin A reduces chondrocyte oxidative stress in chondrocytes and ameliorates mouse osteoarthritis by activating autophagy.
Shen Z; Ji K; Cai Z; Huang C; He X; Xu H; Chen G
Aging (Albany NY); 2021 Mar; 13(7):9820-9837. PubMed ID: 33744850
[TBL] [Abstract][Full Text] [Related]
19. Selective Inhibition of SIRT2 Improves Outcomes in a Lethal Septic Model.
Zhao T; Alam HB; Liu B; Bronson RT; Nikolian VC; Wu E; Chong W; Li Y
Curr Mol Med; 2015; 15(7):634-41. PubMed ID: 26299770
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
